HIGHLIGHTED SPEAKERS
David Aanensen, Professor and Director, Centre for Genomic Pathogen Surveillance, University of Oxford, UK
Kim Abbass, Clinical Coordinator Antimicrobial Stewardship and Pharmacy Practice, Eastern Zone,, Nova Scotia Health
Labeeb Abboud, Chairman & Chief Executive Officer, Global Health Investment Corporation
Nicholas Adomakoh, Global Medical Director, Sandoz
Samuel Aitken, President-Elect, Society of Infectious Diseases Pharmacists (SIDP)
Mark Albrecht, Branch Chief - Antibacterials Program, BARDA
Jose Alexander, Clinical Microbiologist, Director of Microbiology, Virology & Immunology, Advent Health
Arielle Allen, Project Firstline Infection Preventionist, Pennsylvania Department of Health
James Allen, Senior Director - Market Access, bioMérieux, Inc.
Najy Alsayed, Global Therapeutic Area Head - Infectious Diseases Menarini Group, Menarini Group
John Alter, Head of External Affairs, AMR Action Fund
Craig Altier, Professor of Population Medicine & Diagnsostic Sciences, Weill Cornell Medicine
Javad Aman, President & CSO, AbVacc Inc.
Kensey Amaya, Project Officer, HHS/ASPR/BARDA
Anand Anandkumar, Chief Executive Officer, Bugworks
James Anderson, Executive Director, Global Health, IFPMA
Ruth Appleby, Senior Alliance Manager, CARB-X
Phyllis Arthur, Senior Vice President, Infectious Diseases & Emerging Science Policy, Biotechnology Innovation Organization (BIO)
Monisha Ashok, Director, Global Health Initiatives, U.S. International Development Finance Corporation (DFC)
Cristina Baker, Director of Medical Affairs, Cepheid
Ella Balasa, Patient Advocate, Patient Advocate
Ms. Julia Barnes-Weise, Executive Director, GHIAA
Priya Basu, Executive Head, The Pandemic Fund Secretariat, The World Bank
Carolina Batista, Member of DNDi Access Committee, DNDi
Beth Battaglino, Chief Executive Officer, HealthyWomen
Christoph Bausch, PhD, Executive Vice President & Chief Operating Officer, SAB Biotherapeutics Inc.
Lars Behrend, Chief Executive Officer, microphotonX
Ana Isabel Bento, Director of Science, The Rockefeller Foundation
Emma Berntman, Senior Engagement Specialist, FAIRR Initiative
Alexandra Bhatti, Director of U.S. Vaccine Public Policy, Merck
John Billington, Head Commercial Pipeline Policy and Advocacy, GSK
Tim Blauwkamp, Chief Scientific Officer, Karius Inc
Ken Blount, VP of Microbiome Research, Rebiotix, a Ferring Company
Dr Karin Bok, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIAID, NIH
Nagesh Borse, Deputy Chief Health Officer, Project HOPE
Margaret Borys, SVP & Chief Commercial Officer, Shionogi Inc.
Maria Bottazzi, Professor and Codirector Texas Children's Center for Vaccine Developement, Baylor College of Medicine
Kyle Bozentko, Executive Director, Center for New Democratic Processes
Rick Bright, Founder, Bright Global Health
Nichole Brinkman, US Environmental Protection Agency
Juliane Bubeck-Wardenburg, Professor of Pediatrics and Chief, Washington University School of Medicine in St. Louis
Kee Kee Buckley, Filmmaker, Writer, Advocate & C. diff Survivor
Amanda Burkardt, Chief Executive Officer, Phiogen
Bradley Burnam, Patient Advocate & Founder
Paul Burton, CMO, Moderna
Ed Buurman, Director Alliances, CARB-X
Virginia Calega, MD, MBA, FACP, President, VCC Healthcare Solutions LLC
Katy Capers, Associate Director for Communication, Division of Healthcare Quality Promotion, CDC
Lon A. Castle M.D, Chief Medical Officer- Molecular Genetics and Personalized Medicine,, EviCore healthcare
Ricardo Chaves, Executive Medical Director, Clinical Development, Debiopharm
Francesca Chiara, Director of Antimicrobial Resistance Stewardship, Center for Infectious Disease Research & Policy (CIDRAP)
Megan Coffee, Communicable Disease Advisor, International Rescue Committee
Isabel Colbourn, Series Producer, BBC StoryWorks Programme Partnerships
Chris Connelly, Director Of R&D, Streck, Inc.
Alexandre Costa, Senior Health Advisor, UNICEF
Nick Crabb, PhD, Interim Director for Science, Evidence and Analytics, National Institute for Health and Care Excellence
Michael Craig, Senior Advisor for Antimicrobial Resistance, Antimicrobial Resistance Coordination and Strategy Unit, Centers for Disease Control and Prevention
Ms Danielle Craig, Regulatory Affairs Lead Americas, CEPI
Andrea Crisanti, Professor of Molecular Parisitology, Imperial College London
Kathy E. Currie, PharmD, BCPS, Clinical Pharmacist, Providence Regional Medical Center Everett
Natalie D'Amore, Head of External Innovation, Seres Therapeutics Inc
Jessica Dangles, Executive Director - CBIC, Association for Professionals in Infection Control and Epidemiology
Demetre Daskalakis, Director for the Division of HIV Prevention & Former Deputy Coordinator National Mpox Response, CDC
Matthew Davenport, Project Officer, HHS/OS/ASPR/BARDA
Damiano de Felice, Director of Development and External Engagement, CARB-X
Francesca de Rosa, Chief Scientist for Gaming, Center for Advanced Preparedness and Threat Response Simulation
Ms Tara deBoer, Chief Executive Officer, BioAmp Diagnostics
Molly Deiss, Vice President, Marketing, Melinta Therapeutics Inc
Robert Deluccia, Executive Chairman, Acurx Pharmaceuticals
Candace DeMatteis, Vice President, Policy, The Partnership to Fight Infectious Disease (PFID)
Marcelo Der Torossian Torres, Postdoctoral Research Scientist, University of Pennsylvania
Erica DeWald, Chief Communiation Officer, Vaccinate Your Family
Erin Duffy, Chief of Research & Development, CARB-X
Alan W Dunton MD, Non-Executive Director, Recce Pharmaceuticals
Rahul Dwivedi, Access leader, Serious Bacterial Infections, Global Antibiotic Research & Development Partnership (GARDP)
Paul Eder, Senior Scientific Officer, National Institutes of Health
Erika Edwards, Health and Medical Reporter and Writer, NBC News
Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Nada Fadul, Professor - Division of Infectious Diseases & Assistant Dean for Diversity, Equity, and Inclusion (DEI) Education Programs, University of Nebraska Medical Center
Victoria Fan, Senior Fellow, Center for Global Development
Richard Feiner, Academic Member, Columbia University
Cecilia Ferreyra, Head AMR Programme, FIND
Yann Ferrisse, Director, Business Development & Partner Engagement, GARDP
Lynn Filpi, Assistant Director for One Health and Antimicrobial Resistance, Office of Science and Technology Policy – Executive Office of the President
Will Fitzhugh, Software Consultant, Partners In Diagnostics
Diane Flayhart, Director, Global Public Health, BD
Christopher Ford, Vice President, Translational Biology, Seres Therapeutics Inc
Ari Frenkel, Chief Science Officer and Co founder, Arkstone Medical Solutions
Jason Gale, Senior Editor and Biosecurity Correspondent, Bloomberg News
Hayley Gans, Director of Pediatric Infectious Diseases Program for Immunocompromised Host, Stanford University Medical Center
Bruce Gellin, Chief, Global Public Health Strategy, The Rockefeller Foundation
Carl Genberg, Chief Scientific and Development Officer, N8 Medical
Volker Gerdts, Director and Chief Executive Officer, VIDO
Margaret Gilman, Manager, Infection Prevention and Control, Nemours Children’s Hospital, Delaware
Devasena Gnanashanmugam, Vice President, Medical Affairs, Cepheid
James Graham, Chief Executive Officer, Recce Pharmaceuticals
Malin Grape, Ambassador on Antimicrobial Resistance, Ministry of Health & Social Affairs
Authia Gray, Researcher, Institute for Health Metrics and Evaluation (IHME)
David Greenberg, Professor of Infectious Diseases and Microbiology, UT Southwestern Medical Center
Riley Griffin, Health Reporter, Bloomberg
Christian Groendahl, Co-Founder And Chief Executive Officer, SNIPR BIOME
Amy Groom, Director of Immunization Initiatives, University of New Mexico Health Sciences Center, ECHO Institute
Philippe Guibert, Council Chairman, International Corporate Health Leadership Council
Vikas Gupta, Director, MMS Medical Affairs, BD
Javier Guzman, Director, Global Health Policy, Center for Global Development
Janet Haas, Assoicate Editor, American Journal of Infection Control
Douglas Häggström, Management Team, INCATE
Veronica L. Hall, Chief Operating Officer, Clarametyx Biosciences
Celina Hanson, Senior Immunization Technical Advisor, USAID
Kathleen Hefferon, Instructor of Microbiology, Cornell University
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Tom Hess, Director - Life Sciences, GlobalData Plc
Thomas Heymann, President and Chief Executive Officer, Sepsis Alliance
Kimberly Hofmeyer, Project Officer, Biomedical Advanced Research and Development Authority (BARDA)
Karen Hogan, Head of Laboratory Partnerships, Technology Platform, Concentric by Ginkgo Bioworks
Robert Horne, Government Relations Director, The Partnership to Fight Infectious Disease (PFID)
Peter Hotez, Dean, National School Of Tropical Medicine, Co-Director, Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine
Teri Hulett, Founder, Infection Prevention Strategies, LLC
Kevin Ikuta, Research Scientist, Institute for Health Metrics and Evaluation (IHME)
Sujith J Chandy, Executive Director, International Centre for AMR solutions (ICARS)
Ruediger Jankowsky, Chief Executive Officer, AATec Medical
John Jernigan, MD, MS, Chief, Epidemiology Research, and Innovations Branch, Centers for Disease Control and Prevention
Amanda Jezek, Senior Vice President, Public Policy And Government Relations, Infectious Diseases Society of America
Kris Johansen, Associate Director of External Relations, National Institute of Antimicrobial Resistance Research and Education (NIAMMRE)
Mark Jones, Head of Development, Basilea Pharmaceutica Ltd
CarriAyne Jones Parr, Founder, MEND Collective
Devin Jopp, Chief Executive Officer, APIC
Tina Joshi, Associate Professor in Molecular Microbiology, University of Plymouth
Claudine Kabera, Epidemiologist, fda
Sameer Kadri, MD, ICU Physician and AMR Epidemiologist, NIH CLINICAL CENTER
Amy Karachalios, Infection Preventionist, Main Line Health
Rajendra Kasinath, Principal Scientist, Johnson & Johnson
Patrick Keenan, Managing Director, Prevail Partners
Marcy Kelly, Dean School of Science, Manhattan College
Kerrie Kerrie Demarco, Program Management Director, Strategic Analysis, Inc.
Tiffany Kesinger, BSN, RN,CIC, Infection Preventionist, The University of Kansas Health System
Kamran Khan, Founder & CEO, Bluedot
Wes Kim, Director of Global Public Health Programs, American Society for Microbiology
Soong-Hyun KIM, Infectious Disease Team Leader, Principal Research Scientist, K-MEDI hub, New Drug Developement Center
Riko Kimoto, Senior Project Manager, Asia-Europe Foundation
Amy E. Kirby, PhD MPH, Rapid Response Research and Surveillance Branch (Acting Approved), Division of Infectious Disease Readiness and Innovation, CDC
Harry Kleanthous, Executive Vice President, Vaccines R&D Strategy & External Innovation, SK bioscience
Marjorie Korn, Deputy Communications Director, AMR Action Fund
Akhila Kosaraju, Chief Executive Officer and President, Phare Bio
Melanie Kremer, Assistant Chief, Infection Prevention & Control, James A. Haley Veterans' Hospital and Clinics
Michelle Kromm, Principal, Food Forward LLC
Alexandra Kropotova, MD, Executive Vice President & Chief Medical Officer, SAB Biotherapeutics Inc.
Arun Kumar, Vaccine Development Lead, CEPI
Niranjan Kumar, President & Chief Executive Officer, ABS Inc. USA
Eve Lackritz, Deputy Director, Center for Infectious Disease Research & Policy (CIDRAP)
Yohann Lacotte, Project Manager, EU-JAMRAI
Alexander Lai, New Business Development, Vincogen Corporation
Alan Laird, Director, Laboratory Services, Southwest Health System
James Lancaster, CEO, Solenic Medical
Elaine Larson, Senior Scholar in Residence, New York Academy of Medicine
Maria Larsson Ortino, Senior Global ESG Manager, Legal & General Investment Management (LGIM)
Kenneth Lawrence, Executive Director, Seres Therapeutics Inc
Ramanan Laxminarayan, President & Founder, One Health Trust
Bruce Y. Lee, Executive Director, Public Health Computational and Operation Research (PHICOR), Senior Contributor, Forbes
Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School
Benjamin Liu, Assistant Professor of Pediatrics & Pathology, Children’s National Hospital/George Washington Univ
Chelsea Luxen, Co-founder & CEO, ParaNano Wound Care, LLC
Yehoda M. Martei, MD, MSCE, Vice Chief, Diversity, Inclusion and Health Equity, Division of Hematology/Oncology Assistant Professor of Medicine, Hospital of the University of Pennsylvania
Syra Madad, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals
Nita Madhav, Senior Director, Epidemiology & Modeling, Ginkgo Bioworks
Monica Magee, Project Firstline Infection Preventionist, Pennsylvania Department of Health
Jessica Malaty Rivera, Research Assistant, Johns Hopkins Center For Health Security
Apoorva Mandavilli, Health & Science Reporter, New York Times
Mary Manning Lou, Director, Jefferson Center for Infection Prevention and Antibiotic Stewardship
Ms Monique K Mansoura, Executive Director, Global Health Security, Mitre
Anthony Maresso, CO-FOUNDER, Phiogen
Patricia Martin, Managing Director, LimmaTech Biologics AG
Kenneth Martinez, Chief Science Officer, IBEC
Anafi Mataka, Portifolio Lead, African Society for Laboratory Medicine
Sophie Mathewson, Director, Global Access, IAVI
J. Scotch McClure, MBA, Chief Executive Officer, Maxwell Biosciences, Inc.
L. Clifford McDonald, Associate Director for Science in the Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention
Anthony McDonnell, Senior Policy Analyst, Center for Global Development
Timothy Meehan, Senior Laboratory Technical Advisor, Partnership for Supply Chain Management
Mr Greg Merril, Chief Executive Officer, Adaptive Phage Therapeutics
Marc Meyer, Director of Pharmacy Services, Infection Control, Southwest Health System
Sheila Miknyoczki, Program Manager, BARDA
David Milestone, Senior Advisor, Co-Founder & Board Chair for AMP Health, McKinsey & Company
Mary Millard, Patient Advocate, Sepsis Survivor
Melissa Mitchell, Secretariat Lead, AMR Industry Alliance
Gareth Morgan, Head, Global Portfolio Management and AMR Policy., Shionogi Pharma
Andrew Morris, MD, SM(Epi), FRCPC, Professor of Medicine & Medical Director - University Health Network Antimicrobial Stewardship Program, Sinai Health System
Jacob Morton, Global Program Director - Antimicrobial Stewardship, bioMérieux, Inc.
Mirfin Mpundu, Director, React Africa
Aruni Mulgirigama, Global Medical Affairs Lead, Antibiotics, GSK
Jomana Musmar, Executive Director, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, DHHS
Windi Muziasari, Chief Executive Officer, Resistomap
Mohsen Naghavi, Professor, Director of Subnational Burden of Disease Estimation, Institute for Health Metrics and Evaluation (IHME)
Ms Dorottya Nagy-Szakal, Chief Medical Officer, Biotia Inc.
Narayan Nair, Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Federal Drug Administration
Jonas Nguh, President - elect, Maryland Public Health Association
Kaylee Nguyen, Conference Producer, Terrapinn
W Garrett Nichols, Chief Medical Officer, Contrafect
David P. Nicolau, PharmD, FCCP, FIDSA, Chief, Preclinical Development and Commercial Strategies Center for Anti-Infective Research & Development, Hartford Hospital
Mr Michael S Niederman, Professor of Clinical Medicine, Weill Cornell Medicine
John O'Donnell, Vice President, Research, Innoviva Specialty Therapeutics
Mr Paul Offit, Physician, Childrens Hospital of Pennsylvania
Lesley Ogilvie, Director, Global AMR R&D Hub
Pascale Ondoa, Director of Science and New Initiatives, African Society for Laboratory Medicine
Hollis O'Neal, Medical Director of Research, Our Lady of the Lake Regional Medical Center in Baton Rouge
Assaf Oron, Chief Business Officer, Biomx
Kevin Outterson, Professor, Boston University, Executive Director, CARB-X
Lindsay Parish, Project Officer, BARDA
John Parkinson, Senior Editor, Contagion Live
Luna Parry, Regional Grants Coordinator, The Fleming Fund Management Agent
Deepali Patel, Director of International Policy, AMR Action Fund
Robin Patel, Director, Infectious Diseases Laboratory and past Chair, Department of Clinical Microbiology, Mayo Clinic
Tom Patterson, Distinguished Professor of Psychiatry, University of California San Diego
Gabriel Pedone, Global Health Strategic Partnerships Director, bioMérieux
Meghan Pennini, Chief Therapeutics Officer, HCORE, HHS
Kelly Percival, Clinical Pharmacy Specialist, Infectious Diseases, The University of Iowa
David Perlin, Chief Scientist, David Perlin
Jessica Petrillo, Lead, Multilateral Affairs and Policy Team, USAID
Ann Marie Pettis, Former APIC President, Association for Professionals in Infection Control and Epidemiology
Wolfgang Philipp, Acting Director, DG Health Emergency Preparedness and Response Authority (HERA), European Commission
Manise Pierre, Program Officer, American Society for Microbiology
Obadiah Plante, Senior Director, Bacteriology, Infectious Disease Research, Moderna Therapeutics
Ivo Plomen, Business Development & Strategic Partnerships, Viroclinics-DDL
Paul Plummer, Executive Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Nira Pollock, Associate Medical Director of the Infectious Diseases Diagnostic Laboratory, Boston Children's Hospital
Dave Powell, Chief Scientific Officer, LifeArc
Brittanii Prahl, Critical Care Clinical Pharmacist, Providence Regional Medical Center Everett
Lance Price, Professor and Director, Antibiotic Resistance Action Center, George Washington University
Richard A Proctor, Professor Emeritus, University of Wisconsin School of Medicine and Public Health
Robert Purdie, Program Coordinator, Valley Fever Institute
Robert Quigley, Co-Founder & Executive Chairman, International Corporate Health Leadership Council
Miraz Rahman, Professor of Medicinal Chemistry, King's College London
Pilar Ramon-Pardo, Chief, Antimicrobial Resistance Special Program Communicable Diseases Prevention, Control and Elimination, PAHO/WHO
Angela Rasmussen, Principal Research Scientist, VIDO
Rachel Rath, BARDA Alliance Director, Johnson & Johnson Innovation
Maggie Reavis, Infection Preventionist, The University of Kansas Health System
John Redd, Chief Medical Officer, The Medical Countermeasures Coalition
Laurel Redding, Assistant Professor of Epidemiology, University of Pennsylvania
Kyu Y. Rhee, Professor of Medicine and Microbiology and Immunology, Weill Cornell Medicine
Niels Riedemann, Chief Executive Officer and Executive Director of the Board, InflaRx GmbH
Charlotte Robbins, Global Series Lead, BBC StoryWorks Programme Partnerships
David Robinson, Deputy Director, CMC Vaccine Development, Bill & Melinda Gates Foundation
Susan Rogers Van Katwyk, Managing Director, AMR Policy Accelerator
Nadine Rouphael, Executive Director - Hope Clinic, Emory University
Joshua Royal, Principal Scientist, Research & Discovery, Kbio
Ed Rudnic, PhD, Chief Operating Officer and Head of R&D, Maxwell Biosciences, Inc.
Reynolds Salerno, Director, Division of Labratory Systems, CDC
Ana Santos Rutschman, Professor of Law, Villanova University
Tharini Sathiamoorthy, Director of Health Policy, Cepheid
Souleymane Sawadogo, Chief Global Health Officer, Parsyl
Samuel Scarpino, Director of AI + Life Sciences, Northeastern university
Ted Schenkelberg, Senior Vice President and Chief Strategy Officer, The Human Immunome Project
Robert Schooley, Distinguished Professor of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego
Florence Sejourne, Chief Executive Officer, AUROBAC THERAPEUTICS
Craig Serio, Chief Executive Officer, Thread Bioscience Inc
Taylor Sexton, Executive Director, Medical Countermeasures Coaltion
Diane Shader Smith, Independent Public Relations and Communications Professional, Patient Advocate
Heather Shane, Strategy & Alliances, Centre for Genomic Pathogen Surveillance
Hui Shao, President and Chief Executive Officer, Yisheng Biopharma Co. Ltd.
Ribhi Shawar, Supervisory Microbiologist, fda
Merewyn Sheeran, Project Firstline Infection Preventionist, Pennsylvania Department of Health
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Anita Sheoran, Program Manager, BARDA
Chelsey Shivley, Antimicrobial Resistance Coordinator, U.S.D.A. A.P.H.I.S. Veterinary Services
Jill Shotzberger Shotzberger, Senior Director, Public Affairs and Access, Genentech
Richard Sibbel, NIAMME advisor, Executive Veterinary & Health Solutions LLC
Richard Sibbel, Strategic and Technical Lead, Mazen Animal Health
Dawn Sievert, Senior Science Advisor, Antimicrobial Resistance Coordination & Strategy, Centers for Disease Control and Prevention
Alexandra Sifferlin, Health & Science Editor, The New York Times
Ruchika Singhal, President, Medtronic
Henry Skinner, Chief Executive Officer, AMR Action Fund
Ms Ava Skolnik, Associate Director, Health Equity Programs & Partnerships, Merck and Co.
Robert Leo Skov, Scientific Director, International Centre for Antimicrobial Resistance Solutions
Heidi Smith, Clinical Team Leader, CDER, FDA
Boumediene Soufi, Global Head AMR, Sandoz
Subasree Srinivasan, Medical director, GARDP
Luka Srot, Manager, Global Health Security, IFPMA
Mr Mike Stebbins, Vice President, Manufacturing & Threat Countermeasures Division, Advanced Technology International
Steffanie Strathdee, Co-Director, Center for Innovative Phage Applications & Therapeutics
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Edie Stringfellow, VP of Ecosystem Development, Center for Global Health Innovation
Amanda Stucke, Principal, Health Policy & Insights, Economist Impact
Ashim Subedee, Director, Division of Research, Innovation, and Ventures (DRIVe) Catalyst Office, Biomedical Advanced Research and Development Authority (BARDA)
Ralf Sudbrak, Deputy Director, Global AMR R&D Hub
Casey Sullivan, Social Science Analyst, HHS
Anita Suresh, Head of Genomics and Sequencing Unit, FIND
Tim Sweeney, Chief Executive Officer And Co-Founder, Inflammatix
Jessica Swenson, Interdisciplinary Scientist, HHS/ASPR/BARDA
Uzma Syed, Board Member, Sepsis Alliance
Ying Taur, MD, MPH, Associate Professor, Infectious Diseases, Dept. of Subspecialty Medicine, Memorial Sloan Kettering Cancer Centre
Jill Taylor, Senior Advisor for Scientific Affairs, Association of Public Health Laboratories (APHL)
Claudio Ternieden, Executive Director, Water & Wastewater Equipment Manufacturers Association (WWEMA)
George Tetz, Chief Executive Officer, HUMAN MICROBIOLOGY INSTITUTE, INC.
Christopher Thomas, Medical Director: System Quality and Patient Safety, Our Lady of the Lake Regional Medical Center in Baton Rouge
Thomas Tillett, Chief Executive Officer, MBF Therapeutics
Janet Tobias, President & Founder, Global Health Reporting Center
Ms Jane True, VP, mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer
Ephraim Tsalik, VP and Chief Scientific Officer- Infectious Disease, Danaher Diagnostics
Nikki Tyler, Director of partnerships, PEPFAR
Maritza Urrego, Senior Program Officer- Global Public Health Programs,, American Society for Microbiology
Steve Usdin, Senior Editor, BioCentury
Mr Livio Valenti, Senior vice president, Vaxess Technologies, Inc
Beatrice van der Puije, Portfolio Lead, African Society for Laboratory Medicine (ASLM)
Martijn van Gerven, Researcher, The Access to Medicine Foundation
Morgane Vanbiervliet, Manager, Market Intelligence & Business Development, Infectious Diseases, Debiopharm International
Jay Varma, Professor and Director - Cornell Center for Pandemic Prevention & Response, Weill Cornell Medicine
Neil Vora, Pandemic Prevention Fellow, Conservation International
Katrine Wallace, Epidemiologist, University of Illlinois Chicago
David Wallinga, MD, Senior Health Officer, Natural Resources Defense Council
Brenda Waning, Chief, Global Drug Facility (GDF)
Margo Warren, Head of Policy, Access to Medicine Foundation
Collin Weinberger, Senior Advisor, Pandemics & Emerging Threats, US Department of Health and Human Services Office of Global Affairs
Matthew Wellington, Public Health Campaigns Director, Public Interest Research Group (PIRG)
Matthew Wilson, Senior Partner, McKinsey & Company
Aaron Woodall, Chief, Tampa VA Infection Control Division
Adam Woodrow, President & Chief Commercial Officer, Paratek Pharmaceuticals , Inc.
Eve Wool, Senior Research Manager, Institute for Health Metrics and Evaluation (IHME)
Prashant Yadav, Senior Fellow, Center for Global Development
Justin Yang, Co-Founder, Kaibab Health & DMV Bio
In-Kyu Yoon, Director & Global Head of Programmes and Innovative Technology, Coalition for Epidemic Preparedness Innovations
Hesham Yosef, Chief Scientific Officer, microphotonX
Kelly Zabriskie, Enterprise Vice President of Infection Control, Thomas Jefferson University
Rachel Zetts, Senior Officer, Antibiotic Resistance Project, The Pew Charitable Trusts
Shaohua Zhao, Microbiologist, fda
Anne Zink, Chief Medical Officer for the State of Alaska & President of The Association of State and Territorial Health Officials, ASTHO, State of Alaska
Ghada Zoubiane, Head of Partnerships and Stakeholder Engagement, International Centre for AMR solutions (ICARS)
John Zurlo, Director - Division of Infectious Diseases, Thomas Jefferson University
Get involved at Disease Prevention & Control Summit America
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events